Sumitomo Pharma Co., Ltd. (TYO:4506)
1,549.00
+64.00 (4.31%)
Aug 31, 2026, 2:45 PM JST
Sumitomo Pharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Sumitomo Pharma stock has a consensus rating of "Buy" and an average price target of ¥2,071. The average 1-year stock price forecast is 33.73% higher than the current stock price, while the lowest is ¥1,500 (-3.16%) and the highest is ¥2,700 (+74.31%).
Price Target: ¥2,071 (+33.73%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 31, 2026.
Analyst Ratings
The average analyst rating for Sumitomo Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ¥2,400 | Buy | Maintains | ¥2,400 | +54.94% | Jul 31, 2026 |
| Citi | Citi | Sell Maintains ¥1,500 | Sell | Maintains | ¥1,500 | -3.16% | May 26, 2026 |
Financial Forecast
Revenue This Year
561.38B
from 453.29B
Increased by 23.85%
Revenue Next Year
612.16B
from 561.38B
Increased by 9.04%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.